Iniston Mucosidad Y Congestión (Pseudoephedrine Hydrochloride, Guaifenesin)

Pseudoephedrine stimulates α‑adrenergic receptors in the nasal mucosa, causing blood‑vessel constriction that reduces swelling and opens the nasal passages, thereby improving airflow during congestion.

The appropriate dose is determined by a qualified healthcare professional based on the patient’s age, weight, and clinical condition. Patients should follow the prescriber’s instructions and the product label.

Pregnant or nursing individuals should consult their physician before using this product. While limited data exist, healthcare providers will weigh potential benefits against possible risks to mother and child.

Enquiries can be submitted via the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Iniston combines a sympathomimetic decongestant (pseudoephedrine) with an expectorant (guaifenesin), offering both nasal decongestion and mucus thinning. Single‑ingredient decongestants lack the expectorant effect, while cough syrups may not address nasal swelling, making Iniston a broader‑spectrum option for cold‑related congestion.

Store the product at temperatures below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Do not refrigerate or freeze unless the label specifically indicates otherwise.

The medication is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should avoid taking it close to bedtime if it contains stimulant properties that could cause insomnia.

Serious risks include significant elevation of blood pressure, cardiac arrhythmias, severe allergic reactions such as anaphylaxis, and, in rare cases, seizures. Patients experiencing these symptoms should seek immediate medical attention.

Individuals with uncontrolled hypertension, severe coronary artery disease, known hypersensitivity to pseudoephedrine or guaifenesin, or those currently taking monoamine oxidase inhibitors should avoid this product unless directed otherwise by a healthcare professional.